Log in

NASDAQ:PLSE - Pulse Biosciences Stock Price, Forecast & News

$6.85
+0.26 (+3.95 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
$6.17
Now: $6.85
$6.86
50-Day Range
$6.59
MA: $12.13
$15.20
52-Week Range
$6.17
Now: $6.85
$19.77
Volume110,384 shs
Average Volume98,461 shs
Market Capitalization$142.40 million
P/E RatioN/A
Dividend YieldN/A
Beta1.74
Pulse Biosciences, Inc operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PLSE
CUSIPN/A
Phone510-906-4600

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$3.22 per share

Profitability

Net Income$-37,540,000.00

Miscellaneous

Employees54
Market Cap$142.40 million
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable

Receive PLSE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.


Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences Inc (NASDAQ:PLSE) released its quarterly earnings results on Thursday, November, 7th. The company reported ($0.57) EPS for the quarter, beating the Zacks' consensus estimate of ($0.61) by $0.04. View Pulse Biosciences' Earnings History.

When is Pulse Biosciences' next earnings date?

Pulse Biosciences is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Pulse Biosciences.

What price target have analysts set for PLSE?

1 equities research analysts have issued 12-month target prices for Pulse Biosciences' stock. Their forecasts range from $6.00 to $6.00. On average, they anticipate Pulse Biosciences' stock price to reach $6.00 in the next twelve months. This suggests that the stock has a possible downside of 12.4%. View Analyst Price Targets for Pulse Biosciences.

What is the consensus analysts' recommendation for Pulse Biosciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Pulse Biosciences.

Has Pulse Biosciences been receiving favorable news coverage?

News stories about PLSE stock have been trending extremely negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pulse Biosciences earned a daily sentiment score of -4.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Pulse Biosciences.

Are investors shorting Pulse Biosciences?

Pulse Biosciences saw a drop in short interest in the month of February. As of February 14th, there was short interest totalling 2,330,000 shares, a drop of 5.3% from the January 30th total of 2,460,000 shares. Based on an average daily trading volume, of 49,800 shares, the short-interest ratio is presently 46.8 days. Approximately 21.0% of the company's shares are sold short. View Pulse Biosciences' Current Options Chain.

Who are some of Pulse Biosciences' key competitors?

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Energous (WATT), Advanced Micro Devices (AMD), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), AbbVie (ABBV), Fate Therapeutics (FATE), Portola Pharmaceuticals (PTLA), Roku (ROKU) and Exelixis (EXEL).

Who are Pulse Biosciences' key executives?

Pulse Biosciences' management team includes the folowing people:
  • Mr. Darrin R. Uecker, Pres, CEO & Director (Age 53)
  • Mr. Brian B. Dow, CFO, Sr. VP of Fin. & Admin., Treasurer and Sec. (Age 50)
  • Mr. Edward A. Ebbers, Exec. VP & GM of Dermatology (Age 59)
  • Dr. Richard Nuccitelli Ph.D., Chief Science Officer
  • Dr. Holly Hartman Ph.D., J.D., VP of Bus. Devel. & Corp. Strategy

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an initial public offering (IPO) on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO.

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (0.92%), Geode Capital Management LLC (0.75%), Griffin Asset Management Inc. (0.24%), Bank of New York Mellon Corp (0.15%), UBS Group AG (0.07%) and Barclays PLC (0.05%). View Institutional Ownership Trends for Pulse Biosciences.

Which major investors are selling Pulse Biosciences stock?

PLSE stock was sold by a variety of institutional investors in the last quarter, including Steward Partners Investment Advisory LLC. View Insider Buying and Selling for Pulse Biosciences.

Which major investors are buying Pulse Biosciences stock?

PLSE stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, State Street Corp, Barclays PLC, Geode Capital Management LLC, Griffin Asset Management Inc., UBS Group AG, Bank of New York Mellon Corp and Citigroup Inc.. View Insider Buying and Selling for Pulse Biosciences.

How do I buy shares of Pulse Biosciences?

Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $6.85.

How big of a company is Pulse Biosciences?

Pulse Biosciences has a market capitalization of $142.40 million. The company earns $-37,540,000.00 in net income (profit) each year or ($2.20) on an earnings per share basis. Pulse Biosciences employs 54 workers across the globe.View Additional Information About Pulse Biosciences.

What is Pulse Biosciences' official website?

The official website for Pulse Biosciences is http://www.pulsebiosciences.com/.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]


MarketBeat Community Rating for Pulse Biosciences (NASDAQ PLSE)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  196 (Vote Underperform)
Total Votes:  410
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe PLSE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLSE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel